Correspondence on Letter regarding "Long-term prognosis and the need for histologic assessment of chronic hepatitis B in the serological immune tolerant phase"
- PMID: 36788758
- PMCID: PMC10121287
- DOI: 10.3350/cmh.2023.0044
Correspondence on Letter regarding "Long-term prognosis and the need for histologic assessment of chronic hepatitis B in the serological immune tolerant phase"
Keywords: Chronic hepatitis B; Histology; Immune tolerance.
Conflict of interest statement
The authors have no conflicts to disclose.
Comment on
-
Long-term prognosis and the need for histologic assessment of chronic hepatitis B in the serological immune-tolerant phase.Clin Mol Hepatol. 2023 Apr;29(2):482-495. doi: 10.3350/cmh.2022.0322. Epub 2023 Jan 5. Clin Mol Hepatol. 2023. PMID: 36603573 Free PMC article.
-
Letter regarding "Long-term prognosis and the need for histologic assessment of chronic hepatitis B in the serological immune-tolerant phase".Clin Mol Hepatol. 2023 Apr;29(2):510-512. doi: 10.3350/cmh.2023.0018. Epub 2023 Jan 30. Clin Mol Hepatol. 2023. PMID: 36710605 Free PMC article. No abstract available.
References
-
- European Association for the Study of the Liver EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. J Hepatol. 2017;67:370–398. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
